HighPoint Advisor Group’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,085
| Closed | -$489K | – | 986 |
|
|
2025
Q4 | $489K | Buy |
10,085
+162
| +2% | +$8.03K | 0.01% | 674 |
|
|
2025
Q3 | $468K | Buy |
9,923
+226
| +2% | +$10.9K | 0.02% | 411 |
|
|
2025
Q2 | $468K | Buy |
9,697
+142
| +1% | +$7.25K | 0.02% | 390 |
|
|
2025
Q1 | $513K | Buy |
9,555
+570
| +6% | +$30.9K | 0.03% | 353 |
|
|
2024
Q4 | $484K | Buy |
8,985
+601
| +7% | +$30.6K | 0.03% | 386 |
|
|
2024
Q3 | $447K | Buy |
8,384
+263
| +3% | +$14.2K | 0.03% | 382 |
|
|
2024
Q2 | $420K | Sell |
8,121
-52
| -0.6% | -$2.51K | 0.03% | 388 |
|
|
2024
Q1 | $410K | Buy |
8,173
+1,342
| +20% | +$65.5K | 0.03% | 398 |
|
|
2023
Q4 | $338K | Buy |
+6,831
| New | +$334K | 0.02% | 439 |
|
|
2022
Q2 | $204K | Buy |
+4,081
| New | +$217K | 0.02% | 494 |
|
|
2021
Q3 | $222K | Sell |
4,595
-355
| -7% | -$18.1K | 0.02% | 487 |
|
|
2021
Q2 | $261K | Buy |
4,950
+725
| +17% | +$37.8K | 0.03% | 432 |
|
|
2021
Q1 | $214K | Buy |
4,225
+78
| +2% | +$3.75K | 0.02% | 446 |
|
|
2020
Q4 | $203K | Sell |
4,147
-344
| -8% | -$17K | 0.02% | 429 |
|
|
2020
Q3 | $226K | Buy |
4,491
+342
| +8% | +$17.6K | 0.04% | 330 |
|
|
2020
Q2 | $213K | Sell |
4,149
-58
| -1% | -$2.82K | 0.05% | 307 |
|
|
2020
Q1 | $209K | Buy |
+4,207
| New | +$201K | 0.05% | 288 |
|
|
2019
Q4 | – | Sell |
-4,091
| Closed | -$187K | – | 461 |
|
|
2019
Q3 | $187K | Sell |
4,091
-688
| -14% | -$29.7K | 0.04% | 328 |
|
|
2019
Q2 | $201K | Buy |
+4,779
| New | +$203K | 0.05% | 304 |
|
|
2019
Q1 | – | Sell |
-4,793
| Closed | -$202K | – | 353 |
|
|
2018
Q4 | $202K | Sell |
4,793
-750
| -14% | -$33.1K | 0.05% | 295 |
|
|
2018
Q3 | $247K | Buy |
5,543
+464
| +9% | +$19.8K | 0.07% | 261 |
|
|
2018
Q2 | $210K | Sell |
5,079
-2,456
| -33% | -$96.7K | 0.06% | 309 |
|
|
2018
Q1 | $294K | Buy |
7,535
+176
| +2% | +$7.32K | 0.08% | 243 |
|
|
2017
Q4 | $290K | Buy |
7,359
+555
| +8% | +$25.6K | 0.08% | 227 |
|
|
2017
Q3 | $315K | Sell |
6,804
-814
| -11% | -$39.4K | 0.1% | 205 |
|
|
2017
Q2 | $366K | Hold |
7,618
| – | – | 0.12% | 188 |
|
|
2017
Q1 | $366K | Sell |
7,618
-1,849
| -20% | -$78.4K | 0.12% | 188 |
|
|
2016
Q4 | $412K | Sell |
9,467
-180
| -2% | -$7.09K | 0.13% | 187 |
|
|
2016
Q3 | $395K | Buy |
+9,647
| New | +$387K | 0.14% | 180 |
|
Other funds holding SNY
MIP
HighPoint Advisor Group's SNY Position: Q1 2026 in Review
HighPoint Advisor Group sold out of Sanofi (SNY) in Q1 2026, closing a stake of 10,085 shares — an estimated $489K sold.
HighPoint Advisor Group first reported a position in SNY in Q3 2016 and held it in 29 quarters. The position peaked at $513K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- HighPoint Advisor Group reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
- HighPoint Advisor Group sold 10,085 Sanofi shares in Q1 2026, an estimated $489K.
- HighPoint Advisor Group first reported a position in Sanofi in Q3 2016 and held it in 29 quarters.
- HighPoint Advisor Group's Sanofi position peaked at $513K in Q1 2025.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.